Table 7.
Multivariate Cox-regression analysis for predicting TTR and OS in 114 HCC patients with Microvascular Invasion with and without adjuvant Lenvatinib after PSM.
| Variable | Multivariable Analysis (TTR) | Multivariable Analysis (OS) | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P | HR | 95%CI | P | |
|
NLR
>2.4 vs. ≤2.4 |
1.98 | 1.10-3.57 | 0.022 | 2.34 | 1.23-4.46 | 0.010 |
|
Microvascular invasion
M2 vs. M1 |
2.00 | 1.12-3.56 | 0.019 | 2.18 | 1.15-4.13 | 0.017 |
|
Margin
Wide vs. Narrow |
0.51 | 0.28-0.90 | 0.021 | 0.49 | 0.26-0.91 | 0.024 |
|
Lenvatinib
Yes vs. No |
0.55 | 0.31-0.97 | 0.039 | 0.52 | 0.28-0.99 | 0.048 |
Bold values indicate statistical significance (P < 0.05). OS, overall survival; TTR, time to recurrence; HCC, Hepatocellular Carcinoma; PSM, propensity score matching. NLR, neutrophil‐to‐lymphocyte ratio.